LENSAR Inc. Company Profile
NASDAQ: LNSRHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LENSAR at a glance
LENSAR Inc. (NASDAQ: LNSR) is a Medical/Dental Instruments company in the Health Care sector headquartered in Orlando, FL. LENSAR is led by Mr. Nicholas T. Curtis and employs about 150 people. At a market capitalization of $79.2 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001320350, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does LENSAR do?
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Business description based on the company's public filings.
Company information
- Legal name
- LENSAR Inc.
- Ticker
- NASDAQ: LNSR
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Nicholas T. Curtis
- Employees
- 150
- Headquarters
- 2800 Discovery Drive, Orlando, FL, United States
- Phone
- 888 536 7271
- Website
- lensar.com
- Market cap
- $79.24M
- SEC CIK
- 0001320350
Companies similar to LENSAR
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LUNGPulmonx Corporation | 1.84 | +1.66% | $79.02M | vs LNSR |
| SKYASkyAI Inc. | 1.82 | +7.69% | $78.71M | vs LNSR |
| MBOTMicrobot Medical Inc. | 1.07 | 0.00% | $71.87M | vs LNSR |
| SKINSkinHealth Systems Inc. Class A | 0.55 | -3.32% | $71.58M | vs LNSR |
| DXRDaxor Corporation | 10.41 | -0.48% | $60.78M | vs LNSR |
| GUTSFractyl Health Inc. | 4.42 | +4.49% | $58.63M | vs LNSR |
| DRIODarioHealth Corp. | 5.80 | +4.69% | $56.84M | vs LNSR |
| PYPDPolyPid Ltd. | 5.07 | +3.47% | $102.98M | vs LNSR |